Oncolytic virotherapy: basic principles, recent advances and future directions
Danni Lin(Shanghai Normal University), Tingbo Liang(Zhejiang University)
Cited by 386
Related Papers
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
|Signal Transduction and Targeted Therapy|2021|594
Lanosterol reverses protein aggregation in cataracts
|Nature|2015|448
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|The Lancet Oncology|2023|243
mRNA vaccines in disease prevention and treatment
|Signal Transduction and Targeted Therapy|2023|217